CQ HealthBeat: Medicare At This Time Will Continue to Cover Prostate Malignancy Screening The U.

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an unbiased news service editorially, is a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research firm unaffiliated with Kaiser Permanente.. CMS sticks with Medicare protection of PSA test The federal government isn’t changing coverage plans at this time. Meanwhile, several urologists and other medical specialists raise concerns that new suggestions against prostate cancers screening will hurt men’s health. CQ HealthBeat: Medicare ‘At This Time’ Will Continue to Cover Prostate Malignancy Screening The U.S. Preventive Services Task Pressure might have released a controversial final recommendation against routine prostate tumor screening for men, but the move shows up unlikely to affect Medicare insurance -;-; at least for a while.‘The consequences of chronic diseases such as for example atherosclerosis and diabetes on arteries can be traced back again to telomere shortening,’ Alexander says. ‘This means that treatments that can restore healthy telomeres possess great potential.’ ‘What's new here is that we display that PGC1-alpha is certainly regulating telomerase, and that has real beneficial results on cellular stress in a mouse style of atherosclerosis,’ says Shiqin Xiong, PhD, instructor in the division of cardiology and first author of the paper.